| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/04/2004 | CN1518597A Novel fibroblast growth factors |
| 08/04/2004 | CN1518457A Methods of inducing cytotoxic immune response and recombinant simian ademovirus compositions useful therein |
| 08/04/2004 | CN1160469C Identification of genes |
| 08/04/2004 | CN1160463C Human papillomaivirus E6/E7 fusion gene and its efficient expression carrier and fusion protein vaccine |
| 08/04/2004 | CN1160130C Plasmid used directly in intramuscular injection for treating diabetes |
| 08/04/2004 | CN1160125C Immune anticaries DNA vaccine, preparing method and use thereof |
| 08/03/2004 | US6770797 Inducing prolonged in vivo gene expression in a mammal for inhibiting alzheimer's disease associated neuronal cell death |
| 08/03/2004 | US6770749 Nucleic acids coding for both a and b chains of human p53, human leukocyte antigen(hla) restricted murine t-cell receptor (tcr); transformed cd8+ cytotoxic t lymphocytes for immunotherapy of tumors that over-express p53 |
| 08/03/2004 | US6770740 Crosslinked DNA condensate compositions and gene delivery methods |
| 08/03/2004 | US6770620 Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders |
| 08/03/2004 | US6770473 Wild-type and mutant human kinase interacting strathmin (hkis) polypeptides along with cyclin kinase inhibitors containing mutations that prevent their inhibition with serine/ threonine kinases |
| 08/03/2004 | US6770461 High bone mass gene of 11q13.3 |
| 08/03/2004 | US6770458 Tgf- transforming growth factor |
| 08/03/2004 | US6770456 Endogenous retrovirus tumor associated nucleic acids and antigens |
| 08/03/2004 | US6770291 Liposome complexes for increased systemic delivery |
| 08/03/2004 | US6770281 B-cell epitope peptides of HSP 65 |
| 07/29/2004 | WO2004063380A1 Series of recombinant adeno-associated virus useful for inducing rnai pathway and gene therapy |
| 07/29/2004 | WO2004063356A2 Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products |
| 07/29/2004 | WO2004063342A2 Cellular delivery and activation polypeptide-nucleic acid complexes |
| 07/29/2004 | WO2004063332A2 Cancer related genes |
| 07/29/2004 | WO2004063329A2 Modulation of pten expression via oligomeric compounds |
| 07/29/2004 | WO2004063218A1 Obesity-related genes |
| 07/29/2004 | WO2004062694A1 Devices and processes for distribution of genetic material to mammalian limb |
| 07/29/2004 | WO2004062693A1 Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene theraphy |
| 07/29/2004 | WO2004062618A2 Method for in vivo regulation of cardiac muscle contractility |
| 07/29/2004 | WO2004062603A2 Methods of treating lung diseases |
| 07/29/2004 | WO2004062474A2 Smooth muscle cell differentiation with crp, srf and gata factors |
| 07/29/2004 | WO2004062368A1 Expression of zeta negative and zeta positive nucleic acids using a dystrophin gene. |
| 07/29/2004 | WO2004054428A3 Nor-1 (neuron-derived orphan receptor-1), novel diagnostic and therapeutic target for cardiovascular diseases |
| 07/29/2004 | WO2004037856A3 Plasmodium falciparum virulence factor var o |
| 07/29/2004 | WO2004033618A3 Stabilized naked dna compositions |
| 07/29/2004 | WO2004022104A3 Foxp2 and uses thereof |
| 07/29/2004 | WO2004020631A3 Genetic suppression and replacement |
| 07/29/2004 | WO2004011626A3 Assays and methods based on microcompetition with a foreign polynucleotide |
| 07/29/2004 | WO2004004663A3 Compositions and methods for ligament growth and repair |
| 07/29/2004 | WO2003097798A3 Carotene synthase gene and uses therefor |
| 07/29/2004 | WO2003080806A3 Method for production of neutrophils and uses therefor |
| 07/29/2004 | WO2003076596A3 Altering viral tropism |
| 07/29/2004 | WO2003070881A3 RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYPROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/29/2004 | WO2003028634A8 Method of treatment using ligand-immunogen conjugates |
| 07/29/2004 | WO2003022123A3 Methods of kidney transplantation utilizing developing nephric tissue |
| 07/29/2004 | WO2003003941A3 One dose vaccination with mycoplasma hyopneumoniae |
| 07/29/2004 | US20040148653 Triacylglycerol lipases |
| 07/29/2004 | US20040148645 ATP diphosphohydrolase (CD39) gene therapy for inflammatory or thrombotic conditions and transplantation and means therefor |
| 07/29/2004 | US20040147739 Novel anti-infectives |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147718 Nucleotide and protein sequences of lats genes and methods based thereon |
| 07/29/2004 | US20040147488 Method of modifying the release profile of sustained release compositions |
| 07/29/2004 | US20040147476 For therapy and prophylaxis of virus infections, other pathogenic infections or cancers |
| 07/29/2004 | US20040147472 Antisense modulation of transforming growth factor beta receptor II expression |
| 07/29/2004 | US20040147470 Nuclease resistance; for therapy and prophylaxis of disease |
| 07/29/2004 | US20040147469 Inhibiting the expression of primary proteoglycans; inhibiting the expression and/or activity of a chain initiation enzyme; inhibiting the expression and/or activity of a chain elongation enzyme |
| 07/29/2004 | US20040147468 Immunostimulatory nucleic acid molecules |
| 07/29/2004 | US20040147466 For gene expression from a bioabsorbable polymeric network structurally and functionally designed to induce gene expression |
| 07/29/2004 | US20040147438 For therapy of neuroblastoma |
| 07/29/2004 | US20040147436 For therapy of Hemophilia A |
| 07/29/2004 | US20040147027 comprises a double-stranded ribonucleic acid molecule, a cell-penetrating peptide, and a covalent bond linkage; for gene expression inhibition; for transfection, electroporation, liposomal delivery or microinjection; genetic engineering |
| 07/29/2004 | US20040147023 RNA-induced silencing complex (RISC); gene expression inhibition; chimeras; drug targets; genetic engineering |
| 07/29/2004 | US20040147022 comprising at least a portion of a RNA-induced silencing complex (RISC); gene expression inhibition; genetic engineering |
| 07/29/2004 | US20040147004 Comprises nucleotide sequences coding enzymatic polypeptide for use as tool in identifying modulators for diagnosis, treatment and prevention of cancer and cell proliferative disorders |
| 07/29/2004 | US20040147003 Comprises nucleotide sequences coding kinase for use as tool in identifying modulators for treatment and prevention cell proliferative disorders |
| 07/29/2004 | US20040146986 Nucleotide sequences coding transcription factor associated with tumor suppressor activity for use in treatment and prevention of cell proliferative disorders |
| 07/29/2004 | US20040146982 hKIS compositions and methods of use |
| 07/29/2004 | US20040146981 DNA encoding human serine protease D-G |
| 07/29/2004 | US20040146971 Novel p53 inducible protein |
| 07/29/2004 | US20040146964 Assays, methods and means |
| 07/29/2004 | US20040146953 Assay |
| 07/29/2004 | US20040146933 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 07/29/2004 | US20040146932 for detecting, diagnosing, and treating prostate cancer and for measuring hormone responsiveness of prostate cancer cells; genetic engineering |
| 07/29/2004 | US20040146930 for diagnosing susceptibility to a pathological condition based on the presence or absence of mutation; drug screening; genetic engineering |
| 07/29/2004 | US20040146929 for drug screening, in vitro or in vivo diagnosis, and gene therapy; antitumor agents; genetic engineering; kits |
| 07/29/2004 | US20040146903 Methods and compositions for modulating activator protein 1 |
| 07/29/2004 | US20040146902 oligomer complementary to and capable of hybridizing to a selected target nucleic acid and at least one protein comprising at least a portion of an RNA-induced silencing complex |
| 07/29/2004 | US20040146891 Comprises growth factor for diagnosis and treatment of immunological and cell proliferative disorders |
| 07/29/2004 | US20040146882 Human acid sensing ion channel 2b (hASIC2b), process for producing the same, and its use |
| 07/29/2004 | US20040146877 Diagnosis and treatment of cancer:I |
| 07/29/2004 | US20040146856 Viral vector coding antiproliferative agent for treatment of tumors; antitumor agents and artificial chromosome gene therapy |
| 07/29/2004 | US20040146851 Identifying compounds which modulate phosphatidylserine exposure on the surface of megakaryocytes for use in treating thrombosis, bleeding and apoptosis disorders |
| 07/29/2004 | US20040146528 MVA expressing modified HIV envelope, gag, and pol genes |
| 07/29/2004 | US20040146516 Lumen-exposed molecules and methods for targeted delivery |
| 07/29/2004 | US20040146510 Genetically engineered polypeptides as wound healing agents; treatment of nervous system, vision, kidney, and liver disorders; stimulating embryogenesis and angiogenesis; antitumor agents; drug screening, diagnosis |
| 07/29/2004 | US20040146505 Polypeptide comprising portion with part of human fc fragment which binds to CD64 antigen, and portion comprising heterologous T cell epitopes; antitumor and anticarcinogenic agents |
| 07/29/2004 | US20040146504 Anti-IgE vaccines |
| 07/29/2004 | US20040146489 Replication competent adenovirus vectors comprising co-transcribed first and second genes under transcriptional control of a heterologous, target cell-specific transcriptional regulatory element (TRE) |
| 07/29/2004 | US20040146488 Gene expression of protein with ability to chaperon antigenic peptides of tumor cells to antigen-presenting cells (APCs); selective replication in and killilng of tumor cells; immunotherapy; antimetastasis and anticarcinogenic agents |
| 07/29/2004 | US20040146487 Avidin pseudotyped viral vectors and their use |
| 07/29/2004 | US20040146459 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 07/29/2004 | DE10045016B4 Retrovirale Vektoren mit Fremdsequenzinsertion zwischen retroviraler Primerbindungsstelle und retroviralem Spleißdonor Retroviral vectors with Fremdsequenzinsertion between retroviral primer binding site and retroviral splice donor |
| 07/29/2004 | CA2513300A1 Obesity-related genes |
| 07/29/2004 | CA2513249A1 Method for in vivo regulation of cardiac muscle contractility |
| 07/29/2004 | CA2513226A1 Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products |
| 07/29/2004 | CA2513072A1 Cellular delivery and activation polypeptide-nucleic acid complexes |
| 07/29/2004 | CA2512676A1 Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene theraphy |
| 07/29/2004 | CA2512672A1 Methods of treating lung diseases |
| 07/28/2004 | EP1441033A2 Eukaryotic gene expression cassette based on Herpes simplex virus |
| 07/28/2004 | EP1440169A1 Methods and compositions for the treatment and diagnosis of pain disorders using 57749 |
| 07/28/2004 | EP1440166A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777 |
| 07/28/2004 | EP1440165A2 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 07/28/2004 | EP1440163A2 Methods and compositions for the treatment and diagnosis of pain disorders using 46566 |
| 07/28/2004 | EP1440091A1 Nogo receptor homologues and their use |